[HTML][HTML] TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu
A Kunert, T Straetemans, C Govers, C Lamers… - Frontiers in …, 2013 - frontiersin.org
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[引用][C] TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
A Kunert, T Straetemans, C Govers, C Lamers… - Frontiers in …, 2013 - cir.nii.ac.jp
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T
Cell Fitness, and Sensitization of Tumor Milieu | CiNii Research CiNii 国立情報学研究所 学術 …
Cell Fitness, and Sensitization of Tumor Milieu | CiNii Research CiNii 国立情報学研究所 学術 …
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
A Kunert, T Straetemans, C Govers… - Frontiers in …, 2013 - pubmed.ncbi.nlm.nih.gov
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[PDF][PDF] TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu
A Kunert, T Straetemans, C Govers, C Lamers… - researchgate.net
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu
A Kunert, T Straetemans, C Govers… - … and harnessing T …, 2015 - books.google.com
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[PDF][PDF] TCR-ENGINEERED T CELLS MEET NEW CHALLENGES TO TREAT SOLID TUMORS: CHOICE OF ANTIGEN, T CELL FITNESS AND SENSITISATION OF …
A Kunert, T Straetemans, C Govers, C Lamers… - Adoptive T cell …, 2013 - repub.eur.nl
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, t cell fitness, and sensitization of tumor milieu
T Straetemans, C Govers - Frontiers in Immunology, 2013 - research.wur.nl
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[PDF][PDF] TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu
A Kunert, T Straetemans, C Govers, C Lamers… - scienceopen.com
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[PDF][PDF] TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu
A Kunert, T Straetemans, C Govers, C Lamers… - cyberleninka.org
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
[PDF][PDF] TCR-ENGINEERED T CELLS MEET NEW CHALLENGES TO TREAT SOLID TUMORS: CHOICE OF ANTIGEN, T CELL FITNESS AND SENSITISATION OF …
A Kunert, T Straetemans, C Govers, C Lamers… - Adoptive T cell Therapy …, 2013 - core.ac.uk
Adoptive transfer of T cells gene-engineered with antigen-specific T cell receptors (TCRs)
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …
has proven its feasibility and therapeutic potential in the treatment of malignant tumors. To …